| Identification | Back Directory | [Name]
6-Benzothiazolesulfonamide, 2-[[(2S)-2-methyl-3-[[5-(methylthio)-2-pyrimidinyl]amino]propyl]amino]- | [CAS]
2455424-51-6 | [Synonyms]
PCSK9-IN-16
6-Benzothiazolesulfonamide, 2-[[(2S)-2-methyl-3-[[5-(methylthio)-2-pyrimidinyl]amino]propyl]amino]- | [Molecular Formula]
C16H20N6O2S3 | [MOL File]
2455424-51-6.mol | [Molecular Weight]
424.56 |
| Hazard Information | Back Directory | [Uses]
PCSK9-IN-16 is a potent PCSK9 inhibitor. PCSK9-IN-16 is extracted from patent WO2020150474, example 87, has the potential for hypercholesterolemia and other cardiovascular diseases research[1]. | [References]
[1] Michael H, et al. Pcsk9 inhibitors and methods of use thereof. Patent WO2020150474 |
|
|